Table 2.
Outcomes at study endpoint (8 weeks): Infant growth,a breastfeeding continuationb, oral contraceptive usec and satisfaction with breastfeeding and oral contraceptivesc
| Outcome | 2 weeks | 8 weeks | Delta 2 weeks to 8 weeks |
P value | |||
|---|---|---|---|---|---|---|---|
| COC N = 64 |
POP N = 63 |
COC N = 41 |
POP N = 40 |
COC N = 41 |
POP N = 40 |
||
| Infant length (mean) |
51.5 | 51.7 | 56.8 | 57.0 | 5.6 | 5.3 | .49 |
| Infant weight (mean) |
3.7 | 3.7 | 5.08 | 5.20 | 1.42 | 1.52 | .36 |
| Infant occipitofrontal circumference (mean)d |
36.0 | 36.1 | 39.0 | 39.0 | 3.0 | 3.0 | .84 |
| Report of any breastfeedinge |
--- | --- | 41g/64 (64%) |
40g/63 (64%) |
Table 3 NS |
||
| Report of using pillse |
--- | --- | 41/42 (98%) |
40/40 (100%) |
1.00h | ||
| Somewhat or very satisfied with breastfeeding |
95% | 95% | 38/41 (93%) |
38/40 (95%) |
1.00 | ||
| Somewhat or very satisfied with OCs?f |
--- | --- | 41/41 (100%) |
40/40 (100%) |
1.00 | ||
a
Two sample t-test
b
Survival analysis
c
Fisher Exact test
d
One missing value at 2 weeks and 2 missing values at 8 weeks
e
Inclusion criteria required breastfeeding to continue in the study
f
Women did not begin OCs until 2 weeks
g
Still actively breastfeeding at 8 weeks
h
These are not ps of the deltas—just differences at 8 weeks